Literature DB >> 21645621

High levels of human recombinant cyclooxygenase-1 expression in mammalian cells using a novel gene amplification method.

Hiromitsu Yoshimura1, Shingo Sekine, Hisashi Adachi, Yoshikatsu Uematsu, Akiko Mitani, Nobuko Futaki, Noriaki Shimizu.   

Abstract

We report the expression of a high level of human cyclooxygenase-1 (hCOX-1) in mammalian cells using a novel gene amplification method known as the IR/MAR gene amplification system. IR/MAR-plasmids contain a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) and amplify autonomously without a specific induction process. In this study, the IR/MAR-plasmid pΔBN.AR1 was cotransfected with pCAG-COX1, which expresses hCOX-1, into human HEK293T cells, and G418 and blasticidin S double-resistant cells were obtained in about 1month. Real-time PCR and Western blotting revealed that the expressions of hCOX-1 mRNA and protein in both polyclonal and monoclonal cells were remarkably higher than those in only pCAG-COX1-transfected control cells. Southern blotting demonstrated the amplification of the hCOX-1 gene, and the copy number of clone #43 obtained by the cotransfection of pΔBN.AR1 and pCAG-COX1 was more than 20 copies per cell, though that of clone #14 obtained without using the IR/MAR plasmid pΔBN.AR1 was only two copies. These results indicate that a high level of hCOX-1 expression was achieved as a result of hCOX-1 gene amplification. Furthermore, the crude extract from clone #43 showed a strong COX-1 activity, and the activity was inhibited by the representative COX-1 inhibitor indomethacin, with an IC(50) value of 36nM. These results demonstrate that the IR/MAR gene amplification system is a simple but useful method for generating highly productive mammalian cells.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645621     DOI: 10.1016/j.pep.2011.05.009

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  8 in total

Review 1.  Engineering cells to improve protein expression.

Authors:  Su Xiao; Joseph Shiloach; Michael J Betenbaugh
Journal:  Curr Opin Struct Biol       Date:  2014-04-03       Impact factor: 6.809

2.  Dissection of the beta-globin replication-initiation region reveals specific requirements for replicator elements during gene amplification.

Authors:  Naoya Okada; Noriaki Shimizu
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

3.  Amplification of a transgene within a long array of replication origins favors higher gene expression in animal cells.

Authors:  Kiwamu Ohsaki; Yusuke Ohgaki; Noriaki Shimizu
Journal:  PLoS One       Date:  2017-04-12       Impact factor: 3.240

4.  Targeted amplification of a sequence of interest in artificial chromosome in mammalian cells.

Authors:  Manami Asoshina; Genki Myo; Natsuko Tada; Koji Tajino; Noriaki Shimizu
Journal:  Nucleic Acids Res       Date:  2019-06-20       Impact factor: 16.971

5.  Efficient recombinant production in mammalian cells using a novel IR/MAR gene amplification method.

Authors:  Yoshio Araki; Tetsuro Hamafuji; Chiemi Noguchi; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

6.  Fusion of the Dhfr/Mtx and IR/MAR gene amplification methods produces a rapid and efficient method for stable recombinant protein production.

Authors:  Chiemi Noguchi; Yoshio Araki; Daisuke Miki; Noriaki Shimizu
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

7.  Cloning and Characterization of a Human Genomic Sequence that Alleviates Repeat-Induced Gene Silencing.

Authors:  Miki Fukuma; Yuto Ganmyo; Osamu Miura; Takashi Ohyama; Noriaki Shimizu
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

8.  Epigenetic Repeat-Induced Gene Silencing in the Chromosomal and Extrachromosomal Contexts in Human Cells.

Authors:  Sho-Hei Mitsuda; Noriaki Shimizu
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.